Psyence Biomedical (PBM) Assets (2023 - 2026)

Psyence Biomedical's Assets history runs 4 years deep, the most recent figure standing at $17.6 million for Q1 2026.

• On a quarterly basis, Assets rose 140.11% year-over-year to $17.6 million in Q1 2026; TTM through Mar 2026 was $17.6 million, a 140.11% increase from a year earlier, with the FY2026 full-year figure at $17.6 million, up 140.11% from the prior year.
• Assets improved to $17.6 million in Q1 2026 per PBM's latest filing, from $12.8 million in the prior quarter.
• Across five years, Assets topped out at $17.6 million in Q1 2026 and bottomed at $12.68 in Q3 2023.
• The 4-year median for Assets is $2.3 million (2024), against an average of $6.1 million.
• Biggest YoY gain for Assets was 17770964.17% in 2024; the steepest drop was 28.81% in 2024.
• Year by year, Assets stood at $12.68 in 2023, then jumped by 17770964.17% to $2.3 million in 2024, then soared by 468.46% to $12.8 million in 2025, then soared by 37.14% to $17.6 million in 2026.
• Per Business Quant, the three latest PBM Assets figures stand at $17.6 million (Q1 2026), $12.8 million (Q3 2025), and $7.3 million (Q1 2025).